Press "Enter" to skip to content

New patent for Beigene drug BRUKINSA

0
Copyright © DrugPatentWatch. Originally published at New patent for Beigene drug BRUKINSA

Annual Drug Patent Expirations for BRUKINSA
Annual Drug Patent Expirations for BRUKINSA

Brukinsa is a drug marketed by Beigene and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-three patent family members in twenty-four countries.

The generic ingredient in BRUKINSA is zanubrutinib. Additional details are available on the zanubrutinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Beigene drug BRUKINSA
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions